U.S. market Closed. Opens in 1 hour 53 minutes

SBIO | ALPS Medical Breakthroughs ETF Overview

(Stock Exchange: AMEX)
Day's Range 27.89 - 28.78
52 Week Range 27.97 - 42.73
Beta 0.79
Implied Volatility 34.36%
IV Rank 71.18%
Day's Volume 42,343
Average Volume 11,279
Shares Outstanding 3,174,557
Inception Date 2014-12-31
Assets 119,156,809
Asset Class Equity
Expense Ratio 0.50
P/E Ratio N/A
EPS N/A
Dividend Yield 4.43%
Dividend Per Share 1.26
Dividend ExDate N/A
Dividend PayDate N/A
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
*Chart delayed
Watching at SBIO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SBIO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙